Trial intelligence / Profile preview

Ticagrelor versus clopidogrel in ST-elevation myocardial infarction

IRCT20170619034621N3Phase 2Completed

Sponsor
Rajaie Cardiovascular Medical and Research Center
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in myocardial infarction (MI) comparing Ticagrelor arm with Clopidogrel arm (2 arms). Primary endpoint: myocardial resistance index. Started Mar 2020; status: completed.

02

Drugs

ticagrelorclopidogrel
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on IRCT20170619034621N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170619034621N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call